TYLER, Texas – Directors inflated the price of Adeptus Health shares with false and misleading statements, and the price dropped by $21.52 a share or 71 percent in two days when the truth emerged, shareholders say in a federal class action.
Categories /
Securities
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.

